|

Placebo oral tablet Clinical Trials

20 actively recruiting trials across 6 locations

▼ -1 trial since June 2026

Also known as: Control group, Matching placebo, Placebo, Placebo comparator

Pipeline

Early 1: 1Phase 2: 7Phase 3: 4Phase 4: 4Phase 1/2: 1Phase 2/3: 1

Top Sponsors

  • Yonsei University1
  • Université de Sherbrooke1
  • University of Texas at Austin1
  • University of Maryland, Baltimore1
  • University of Manitoba1

Indications

Other13 trials

"The Effect of Memantine on the Prevention and Amelioration of Paclitaxel-induced Toxicity in Breast Cancer Patients"
Phase 2
Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy
Phase 3
Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients
Phase 3
Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Phase 2/3
Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapy
Phase 2
Measurement of the Hippocampal Theta Rhythm From the Outer Ear Canal
N/A
Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose
Phase 4
Protecting the Kidney's Proximal Tubules From Platinum-Based Chemotherapy Toxicity
Phase 2
Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.
N/A
The Effect of Gliatamin (Chonline Alphoscerate) on Depressive Mood in Type 2 Diabetes Patients
Phase 4
The MASTER Study (MAmmary Cancer STatin ER Positive Study)
Phase 3
To Evaluate the Efficacy and Safety of TYNADOTE® in the Treatment of Acetaminophen Overdose
Phase 2
iTBS+D-Cycloserine for Youth Suicide
Phase 2

Baltimore, Maryland2 trials

Allopregnanolone and Dynamic GABA-A Receptor Plasticity in Selective Serotonin Reuptake Inhibitor Responsive Premenstrual Dysphoric Disorder

Reproductive Mental Health Center

Phase 4
The Effects of Fluoxetine and/or DHEA

University of Maryland

Early 1

La Jolla, California1 trial

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

University of California, San Diego (UCSD) - Medical Center

Phase 3

San Francisco, California1 trial

RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy

University of California

Phase 2

Chicago, Illinois1 trial

Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 2

Austin, Texas1 trial

Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease

The University of Texas at Austin

Phase 4

Lubbock, Texas1 trial

Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction

Texas Tech University Health Sciences Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.